L. Casali (Pavia, Italy)
Two year (2000-2001) experience of treatment of pediatric tuberculosis in outpatient department in Latvia
Z. Lauska, I. Ozere, A. Skangale, A. Jagmane, V. Kalnina (Riga, Latvia)
|  |
An audit of adherence to antituberculous drugs using a new, rapid, point of care test for isoniazid metabolites
R. J. Whitfield, G. F. Cope (Croydon, Birmingham, United Kingdom)
| |
Empirical treatment for tuberculosis: survey of cases treated over a period of two years
S. M. Tariq, V. Mak ()
| |
Treatment efficacy of MDR TB based on drug susceptibility testing with microchip technology
I. A. Vassilieva, L. N. Tchernousova (Moscow, Russia)
| |
Anti tubercular chemoprophylaxis regimens in HIV seropositives with latent tuberculosis
M. B. N. B. Prasad, K. Shashirekha, S. C. Tiwari (Ranchi, India)
| |
In-vitro and in-vivo activity of rifampicin and rifabutin against multi-drug-resistant strains of mycobacterium tuberculosis
S. P. Vaidya, M. G. Kulkarni, G. V. Koppikar (Mumbai, India)
| |
Latent tuberculosis (infection). Evaluation of a short course treatment with isoniazid, rifampin and pyrazinamid
R. Duarte, C. Gomes, P. Pamplona, J. Carvalho, A. Pimpão, C. Ventura, C. Gil, L. Andrade, M. Villar (Portugal)
| |
A cholesterol-rich diet accelerates the negativization of sputum culture in pulmonary tuberculosis: a controlled clinical trial
C. Pérez-Guzmán, M. H. Vargas, N. Bazavilvazo, F. Quiñonez, A. Aguilar, A. Torres, H. Villarreal, J. Loeza, A. García, I. Estrada, V. López, L. Infante (Mexico DF, Mexico)
| |